Skip to content
IBD Digital logo

IBD 50, Stock Checkup and ratings, at $379 a year after the intro.

Listing reviewed November 19, 2026See plans

The Bottom Line

Pros

  • Both the intro, the monthly renewal and the $379 annual plan are published on IBD's official offer page, read on 19 November 2026.
  • A complete, named methodology (IBD lists, Stock Checkup, Composite Score) with a screener covering more than 9,000 names.
  • The page states you can cancel any time.

Cons

  • After the intro, $44.95 a month is $539.40 a year if you stay monthly, and the annual plan at $379 is still the most expensive yearly price on this list.
  • The $20 intro lasts only two months; the regular price should be budgeted from month three.
  • The product is built around IBD's growth-stock system, which will not suit every investing style.

What is IBD Digital?

Sources read on the date shown
IBD Digital is Investor's Business Daily's paid research service: stock lists, proprietary ratings and market analysis built on the IBD Methodology created by William O'Neil. On the official IBD Digital offer page we read on 19 November 2026, new members pay $20 for the first two months, then $44.95 a month. The same FAQ states an annual plan at $379 a year, described as saving more than $160 versus monthly billing. The page lists the IBD 50 and other “best stocks to buy” lists, IBD Stock Checkup (proprietary ratings and more than 25 technical and fundamental data points), a screener covering more than 9,000 stocks and ETFs, and daily analysis such as “The Big Picture.” Ratings include 1–99 and A–E scores and a 1–99 IBD Composite Score. The page says the lists are curated by algorithms trained on more than 100 years of market data, and that membership can be cancelled any time. IBD Digital is a growth-stock list and ratings product, not a two-recommendation newsletter and not a fund-research terminal.
Sourceinvestors.com ↗

Key details

New members: $20 for two months, then $44.95 a monthAnnual plan $379 a yearIBD 50 and other stock listsIBD Stock Checkup and Composite ScoreScreener of more than 9,000 stocks and ETFs

Explore more